Chemoprevention of Head and Neck Cancer by Green Tea Extract: EGCG
Author Information
Author(s): Masuda Muneyuki, Wakasaki Takahiro, Toh Satoshi, Shimizu Masahito, Adachi Seiji
Primary Institution: Kyushu Koseinenkin Hospital
Hypothesis
Can green tea extract, specifically EGCG, effectively prevent head and neck squamous cell carcinoma (HNSCC)?
Conclusion
EGCG shows promise as a chemopreventive agent for HNSCC, demonstrating clinical efficacy and unique biological effects.
Supporting Evidence
- EGCG administration showed significantly higher response rates in high-dose groups compared to lower doses and placebo.
- EGCG inhibited the incidence of second metachronous colon adenoma in treated patients.
- Patients with high-grade prostate intraepithelial neoplasia had a lower incidence of prostate cancer when treated with EGCG.
Takeaway
Drinking green tea might help prevent a type of throat cancer by using a special ingredient called EGCG.
Methodology
The study reviewed various trials and evidence regarding the effects of EGCG on patients with high-risk oral premalignant lesions and other cancers.
Limitations
The clinical efficacy of EGCG is still debated due to varying concentrations used in studies compared to those achievable in humans.
Participant Demographics
Patients with high-risk oral premalignant lesions and other malignancies.
Statistical Information
P-Value
p = .03
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website